2024-517851-11-00
Recruiting
Phase 1
A prospective, single-center phase I pilot study to assess the tissue activity of multidrug resistance-associated protein 1 with positron emission tomography
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Medical University Of Vienna
- Enrollment
- 40
- Locations
- 1
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Department of Clinical Pharmacology
Scientific
Medical University Of Vienna
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 2
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and PharmacokineticsNCT07260500Changchun GeneScience Pharmaceutical Co., Ltd.72
Active, not recruiting
Phase 3
A study to evaluate the efficacy and safety of Clascoterone solution in treatment of male pattern hair loss.2023-504421-39-00Cassiopea S.p.A.629
Not yet recruiting
Not Applicable
Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital MonitoringNCT07260721Yonsei University100
Not yet recruiting
Not Applicable
A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple MastectomyNCT07257003Du Zhenggui150
Not yet recruiting
Phase 1
A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS2023-504746-54-00Tranquis Therapeutics Inc.16